The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
The effects of protein corona on in vivo fate of nanocarriers
Abstract
With the emerging advances in utilizing nanocarriers for biomedical applications, a molecular-level understanding of the in vivo fate of nanocarriers is necessary. After administration into human fluids, nanocarriers can attract proteins onto their surfaces, forming an assembled adsorption layer called protein corona (PC). The formed PC can influence the physicochemical properties and subsequently determine nanocarriers' biological behaviors. Therefore, an in-depth understanding of the features and effects of the PC on the nanocarriers' surface is the first and most important step towards controlling their in vivo fate. This review introduces fundamental knowledge such as the definition, formation, composition, conformation, and characterization of the PC, emphasizing the in vivo environmental factors that control the PC formation. The effect of PC on the physicochemical properties and thus biological behaviors of nanocarriers was then presented and thoroughly discussed. Finally, we proposed the design strategies available for engineering PC onto nanocarriers to manipulate them with the desired surface properties and achieve the best biomedical outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Self-citationOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Cedervall, T., Lynch, I., Lindman, S., Berggård, T., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608582104 · Cited by 3,281
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Peters, T. (1985) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60065-0 · Cited by 2,181
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Protein-nanoparticle interactions
Lynch, I., & Dawson, K. A. (2008) · Nano Today · doi:10.1016/s1748-0132(08)70014-8 · Cited by 1,727
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akinc, A., Maier, M. A., Manoharan, M., Fitzgerald, K., Jayaraman, M., Barros, S., Ansell, S., Du, X., Hope, M. J., Madden, T. D., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0591-y · Cited by 1,636
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C.-C., & Bu, G. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0228-7 · Cited by 1,425
Schöttler, S., Becker, G., Winzen, S., Steinbach, T., Mohr, K., Landfester, K., Mailänder, V., & Wurm, F. R. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.330 · Cited by 1,272
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261
Time Evolution of the Nanoparticle Protein Corona
Casals, E., Pfaller, T., Duschl, A., Oostingh, G. J., & Puntes, V. (2010) · ACS Nano · doi:10.1021/nn901372t · Cited by 1,211
Lesniak, A., Fenaroli, F., Monopoli, M. P., Åberg, C., Dawson, K. A., & Salvati, A. (2012) · ACS Nano · doi:10.1021/nn300223w · Cited by 1,020
Binding of blood proteins to carbon nanotubes reduces cytotoxicity
Ge, C., Du, J., Zhao, L., Wang, L., Liu, Y., Li, D., Yang, Y., Zhou, R., Zhao, Y., Chai, Z., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105270108 · Cited by 940
Protein Corona-Mediated Mitigation of Cytotoxicity of Graphene Oxide
Hu, W., Peng, C., Lv, M., Li, X., Zhang, Y., Chen, N., Fan, C., & Huang, Q. (2011) · ACS Nano · doi:10.1021/nn200021j · Cited by 895
Self-citationNanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation
Deng, Z. J., Liang, M., Monteiro, M., Toth, I., & Minchin, R. F. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2010.250 · Cited by 893
Pelaz, B., del Pino, P., Maffre, P., Hartmann, R., Gallego, M., Rivera-Fernández, S., de la Fuente, J. M., Nienhaus, G. U., & Parak, W. J. (2015) · ACS Nano · doi:10.1021/acsnano.5b01326 · Cited by 890
Enhancing cancer immunotherapy with nanomedicine
Irvine, D. J., & Dane, E. L. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0269-6 · Cited by 882
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801
The Evolution of the Protein Corona around Nanoparticles: A Test Study
Lundqvist, M., Stigler, J., Cedervall, T., Berggård, T., Flanagan, M. B., Lynch, I., Elia, G., & Dawson, K. (2011) · ACS Nano · doi:10.1021/nn202458g · Cited by 752
Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology.
Ashton, N. J., Pascoal, T. A., Karikari, T. K., Benedet, A. L., Lantero-Rodriguez, J., Brinkmalm, G., Snellman, A., Schöll, M., Troakes, C., Hye, A., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02275-6 · Cited by 719
Bertrand, N., Grenier, P., Mahmoudi, M., Lima, E. M., Appel, E. A., Dormont, F., Lim, J.-M., Karnik, R., Langer, R., & Farokhzad, O. C. (2017) · Nature Communications · doi:10.1038/s41467-017-00600-w · Cited by 708
Anselmo, A. C., Zhang, M., Kumar, S., Vogus, D. R., Menegatti, S., Helgeson, M. E., & Mitragotri, S. (2015) · ACS Nano · doi:10.1021/acsnano.5b00147 · Cited by 643
Protein corona: a new approach for nanomedicine design
Nguyen, V. H., & Lee, B.-J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s129300 · Cited by 638
Effect of the surface modification, size, and shape on cellular uptake of nanoparticles
Salatin, S., Maleki Dizaj, S., & Yari Khosroushahi, A. (2015) · Cell Biology International · doi:10.1002/cbin.10459 · Cited by 625
Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo
Chen, F., Wang, G., Griffin, J. I., Brenneman, B., Banda, N. K., Holers, V. M., Backos, D. S., Wu, L., Moghimi, S. M., & Simberg, D. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2016.269 · Cited by 599
Hühn, D., Kantner, K., Geidel, C., Brandholt, S., De Cock, I., Soenen, S. J. H., Rivera_Gil, P., Montenegro, J.-M., Braeckmans, K., Müllen, K., et al. (2013) · ACS Nano · doi:10.1021/nn3059295 · Cited by 580
Nanoparticle–Cell Interactions: Molecular Structure of the Protein Corona and Cellular Outcomes
Fleischer, C. C., & Payne, C. K. (2014) · Accounts of Chemical Research · doi:10.1021/ar500190q · Cited by 575
Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases
Choi, H. M., Doss, H. M., & Kim, K. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041219 · Cited by 510
Structure and Function of Human and Murine Receptors for IgG
Unkeless, J. C., Scigliano, E., & Freedman, V. H. (1988) · Annual Review of Immunology · doi:10.1146/annurev.iy.06.040188.001343 · Cited by 470
Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers
Zhao, Z., Ukidve, A., Krishnan, V., & Mitragotri, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.002 · Cited by 444
Hemopexin: structure, function, and regulation
Tolosano, E., & Altruda, F. (2002) · DNA and Cell Biology · doi:10.1089/104454902753759717 · Cited by 426
Treuel, L., Brandholt, S., Maffre, P., Wiegele, S., Shang, L., & Nienhaus, G. U. (2014) · ACS Nano · doi:10.1021/nn405019v · Cited by 419
Barz, M., Luxenhofer, R., Zentel, R., & Vicent, M. J. (2011) · Polymer Chemistry · doi:10.1039/c0py00406e · Cited by 418
Cloaking nanoparticles with protein corona shield for targeted drug delivery.
Oh, J. Y., Kim, H. S., Palanikumar, L., Go, E. M., Jana, B., Park, S. A., Kim, H. Y., Kim, K., Seo, J. K., Kwak, S. K., et al. (2018) · Nature communications · doi:10.1038/s41467-018-06979-4 · Cited by 409
Delivering the power of nanomedicine to patients today
Germain, M., Caputo, F., Metcalfe, S., Tosi, G., Spring, K., Åslund, A. K. O., Pottier, A., Schiffelers, R., Ceccaldi, A., & Schmid, R. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.007 · Cited by 405
Effect of Adsorbed Proteins on the Wettability of Hydrophilic and Hydrophobic Solids
VROMAN, L. (1962) · Nature · doi:10.1038/196476a0 · Cited by 403
Environmental dimensions of the protein corona
Wheeler, K. E., Chetwynd, A. J., Fahy, K. M., Hong, B. S., Tochihuitl, J. A., Foster, L. A., & Lynch, I. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00924-1 · Cited by 400
Rampado, R., Crotti, S., Caliceti, P., Pucciarelli, S., & Agostini, M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00166 · Cited by 390
Piella, J., Bastús, N. G., & Puntes, V. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00575 · Cited by 382
Lindman, S., Lynch, I., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Nano Letters · doi:10.1021/nl062743+ · Cited by 377
In vivo formation of protein corona on gold nanoparticles. The effect of their size and shape
García-Álvarez, R., Hadjidemetriou, M., Sánchez-Iglesias, A., Liz-Marzán, L. M., & Kostarelos, K. (2018) · Nanoscale · doi:10.1039/c7nr08322j · Cited by 373
Ishida, T., Harada, M., Wang, X. Y., Ichihara, M., Irimura, K., & Kiwada, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.003 · Cited by 365
Mapping protein binding sites on the biomolecular corona of nanoparticles
Kelly, P. M., Åberg, C., Polo, E., O'Connell, A., Cookman, J., Fallon, J., Krpetić, Ž., & Dawson, K. A. (2015) · Nature Nanotechnology · doi:10.1038/nnano.2015.47 · Cited by 360
Hadjidemetriou, M., Al-Ahmady, Z., Mazza, M., Collins, R. F., Dawson, K., & Kostarelos, K. (2015) · ACS Nano · doi:10.1021/acsnano.5b03300 · Cited by 358
Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption
Gessner, A., Waicz, R., Lieske, A., Paulke, B.-R., Mäder, K., & Müller, R. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00432-9 · Cited by 358
Saha, K., Rahimi, M., Yazdani, M., Kim, S. T., Moyano, D. F., Hou, S., Das, R., Mout, R., Rezaee, F., Mahmoudi, M., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b00053 · Cited by 355
AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience
Adler-Moore, J., & Proffitt, R. T. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.21 · Cited by 339
Brain-targeted drug delivery by manipulating protein corona functions
Zhang, Z., Guan, J., Jiang, Z., Yang, Y., Liu, J., Hua, W., Mao, Y., Li, C., Lu, W., Qian, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11593-z · Cited by 334
Temperature: The “Ignored” Factor at the NanoBio Interface
Mahmoudi, M., Abdelmonem, A. M., Behzadi, S., Clement, J. H., Dutz, S., Ejtehadi, M. R., Hartmann, R., Kantner, K., Linne, U., Maffre, P., et al. (2013) · ACS Nano · doi:10.1021/nn305337c · Cited by 333
Yan, Y., Gause, K. T., Kamphuis, M. M. J., Ang, C.-S., O’Brien-Simpson, N. M., Lenzo, J. C., Reynolds, E. C., Nice, E. C., & Caruso, F. (2013) · ACS Nano · doi:10.1021/nn404481f · Cited by 322
Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake
Mirshafiee, V., Kim, R., Park, S., Mahmoudi, M., & Kraft, M. L. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.019 · Cited by 316
Vu, V. P., Gifford, G. B., Chen, F., Benasutti, H., Wang, G., Groman, E. V., Scheinman, R., Saba, L., Moghimi, S. M., & Simberg, D. (2019) · Nature Nanotechnology · doi:10.1038/s41565-018-0344-3 · Cited by 309
Apolipoprotein A-I: structure–function relationships
Frank, P. G., & Marcel, Y. L. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32028-9 · Cited by 308
Personalized protein corona on nanoparticles and its clinical implications
Corbo, C., Molinaro, R., Tabatabaei, M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Biomaterials Science · doi:10.1039/c6bm00921b · Cited by 308
Estimation of the increase in solubility of drugs as a function of bile salt concentration
Mithani, S. D., Bakatselou, V., TenHoor, C. N., & Dressman, J. B. (1996) · Pharmaceutical Research · doi:10.1023/a:1016062224568 · Cited by 303
Cheng, X., Tian, X., Wu, A., Li, J., Tian, J., Chong, Y., Chai, Z., Zhao, Y., Chen, C., & Ge, C. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b04290 · Cited by 300
Nanoparticles for Imaging, Sensing, and Therapeutic Intervention
Bogart, L. K., Pourroy, G., Murphy, C. J., Puntes, V., Pellegrino, T., Rosenblum, D., Peer, D., & Lévy, R. (2014) · ACS Nano · doi:10.1021/nn500962q · Cited by 295
Fibronectin in development and wound healing
Patten, J., & Wang, K. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.005 · Cited by 295
Park, S. J. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s254808 · Cited by 293
Time Evolution of Nanoparticle–Protein Corona in Human Plasma: Relevance for Targeted Drug Delivery
Barrán-Berdón, A. L., Pozzi, D., Caracciolo, G., Capriotti, A. L., Caruso, G., Cavaliere, C., Riccioli, A., Palchetti, S., & Laganà, A. (2013) · Langmuir · doi:10.1021/la401192x · Cited by 289
Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona
Tonigold, M., Simon, J., Estupiñán, D., Kokkinopoulou, M., Reinholz, J., Kintzel, U., Kaltbeitzel, A., Renz, P., Domogalla, M. P., Steinbrink, K., et al. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0171-6 · Cited by 289
Detecting Cryptic Epitopes Created by Nanoparticles
Lynch, I., Dawson, K. A., & Linse, S. (2006) · Science's STKE · doi:10.1126/stke.3272006pe14 · Cited by 268
Serum heat inactivation affects protein corona composition and nanoparticle uptake
Lesniak, A., Campbell, A., Monopoli, M. P., Lynch, I., Salvati, A., & Dawson, K. A. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.049 · Cited by 266
The protein corona and its effects on nanoparticle-based drug delivery systems
Li, H., Wang, Y., Tang, Q., Yin, D., Tang, C., He, E., Zou, L., & Peng, Q. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.05.019 · Cited by 265
Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide
Hajipour, M. J., Raheb, J., Akhavan, O., Arjmand, S., Mashinchian, O., Rahman, M., Abdolahad, M., Serpooshan, V., Laurent, S., & Mahmoudi, M. (2015) · Nanoscale · doi:10.1039/c5nr00520e · Cited by 256
Understanding the Lipid and Protein Corona Formation on Different Sized Polymeric Nanoparticles
Lima, T., Bernfur, K., Vilanova, M., & Cedervall, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-57943-6 · Cited by 250
Tailoring the component of protein corona via simple chemistry
Lu, X., Xu, P., Ding, H.-M., Yu, Y.-S., Huo, D., & Ma, Y.-Q. (2019) · Nature Communications · doi:10.1038/s41467-019-12470-5 · Cited by 246
The ancillary effects of nanoparticles and their implications for nanomedicine
Stater, E. P., Sonay, A. Y., Hart, C., & Grimm, J. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-01017-9 · Cited by 245
The protein corona of circulating PEGylated liposomes
Palchetti, S., Colapicchioni, V., Digiacomo, L., Caracciolo, G., Pozzi, D., Capriotti, A. L., La Barbera, G., & Laganà, A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.11.012 · Cited by 233
Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses
Tay, M. Z., Wiehe, K., & Pollara, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00332 · Cited by 229
Suzuki, T., Suzuki, Y., Hihara, T., Kubara, K., Kondo, K., Hyodo, K., Yamazaki, K., Ishida, T., & Ishihara, H. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119792 · Cited by 225
Mohammad-Beigi, H., Hayashi, Y., Zeuthen, C. M., Eskandari, H., Scavenius, C., Juul-Madsen, K., Vorup-Jensen, T., Enghild, J. J., & Sutherland, D. S. (2020) · Nature Communications · doi:10.1038/s41467-020-18237-7 · Cited by 218
Hadjidemetriou, M., Al-Ahmady, Z., & Kostarelos, K. (2016) · Nanoscale · doi:10.1039/c5nr09158f · Cited by 214
Effects of shear on proteins in solution
Thomas, C. R., & Geer, D. (2011) · Biotechnology Letters · doi:10.1007/s10529-010-0469-4 · Cited by 213
The effects of shear flow on protein structure and function
Bekard, I. B., Asimakis, P., Bertolini, J., & Dunstan, D. E. (2011) · Biopolymers · doi:10.1002/bip.21646 · Cited by 206
Haptoglobin: function and polymorphism.
Wassell, J. (2000) · PubMed · Cited by 204
Mo, J., Xie, Q., Wei, W., & Zhao, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04873-7 · Cited by 204
Zhu, X., Xu, Y., Solis, L. M., Tao, W., Wang, L., Behrens, C., Xu, X., Zhao, L., Liu, D., Wu, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505629112 · Cited by 203
Ding, L., Yao, C., Yin, X., Li, C., Huang, Y., Wu, M., Wang, B., Guo, X., Wang, Y., & Wu, M. (2018) · Small · doi:10.1002/smll.201801451 · Cited by 202
The Influence of Nanoparticle Shape on Protein Corona Formation
Madathiparambil Visalakshan, R., González García, L. E., Benzigar, M. R., Ghazaryan, A., Simon, J., Mierczynska‐Vasilev, A., Michl, T. D., Vinu, A., Mailänder, V., Morsbach, S., et al. (2020) · Small · doi:10.1002/smll.202000285 · Cited by 201
Mitchell, M. J., & King, M. R. (2013) · New Journal of Physics · doi:10.1088/1367-2630/15/1/015008 · Cited by 196
Ogawara, K.-I., Furumoto, K., Nagayama, S., Minato, K., Higaki, K., Kai, T., & Kimura, T. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.028 · Cited by 195
Bélteky, P., Rónavári, A., Zakupszky, D., Boka, E., Igaz, N., Szerencsés, B., Pfeiffer, I., Vágvölgyi, C., Kiricsi, M., & Kónya, Z. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s304138 · Cited by 195
The charged groups at the interface of some blood cells
Bangham, A. D., Pethica, B. A., & Seaman, G. V. F. (1958) · Biochemical Journal · doi:10.1042/bj0690012 · Cited by 193
Fever and the heat shock response: distinct, partially overlapping processes
Hasday, J. D., & Singh, I. S. (2000) · Cell Stress & Chaperones · doi:10.1379/1466-1268(2000)005<0471:fathsr>2.0.co;2 · Cited by 189
Hard and Soft Protein Corona of Nanomaterials: Analysis and Relevance
García-Álvarez, R., & Vallet-Regí, M. (2021) · Nanomaterials · doi:10.3390/nano11040888 · Cited by 187
GABE, I. T., GAULT, J. H., ROSS, J., MASON, D. T., MILLS, C. J., SCHILLINGFORD, J. P., & BRAUNWALD, E. (1969) · Circulation · doi:10.1161/01.cir.40.5.603 · Cited by 186
Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles
Partikel, K., Korte, R., Stein, N. C., Mulac, D., Herrmann, F. C., Humpf, H.-U., & Langer, K. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.05.006 · Cited by 184
Xiao, W., Wang, Y., Zhang, H., Liu, Y., Xie, R., He, X., Zhou, Y., Liang, L., & Gao, H. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120888 · Cited by 174
Dynamic protein coronas revealed as a modulator of silver nanoparticle sulphidation in vitro
Miclăuş, T., Beer, C., Chevallier, J., Scavenius, C., Bochenkov, V. E., Enghild, J. J., & Sutherland, D. S. (2016) · Nature Communications · doi:10.1038/ncomms11770 · Cited by 174
Polymeric Nanoparticles with Neglectable Protein Corona
Alberg, I., Kramer, S., Schinnerer, M., Hu, Q., Seidl, C., Leps, C., Drude, N., Möckel, D., Rijcken, C., Lammers, T., et al. (2020) · Small · doi:10.1002/smll.201907574 · Cited by 173
Dolan, J. M., Meng, H., Singh, S., Paluch, R., & Kolega, J. (2011) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0267-8 · Cited by 172
Fibrinogen: Structure, Function, and Surface Interactions
Fuss, C., Palmaz, J. C., & Sprague, E. A. (2001) · Journal of Vascular and Interventional Radiology · doi:10.1016/s1051-0443(07)61437-7 · Cited by 172
The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof‐of‐Concept Clinical Study
Hadjidemetriou, M., McAdam, S., Garner, G., Thackeray, C., Knight, D., Smith, D., Al‐Ahmady, Z., Mazza, M., Rogan, J., Clamp, A., et al. (2019) · Advanced Materials · doi:10.1002/adma.201803335 · Cited by 171
Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles
Greish, K., Thiagarajan, G., Herd, H., Price, R., Bauer, H., Hubbard, D., Burckle, A., Sadekar, S., Yu, T., Anwar, A., et al. (2012) · Nanotoxicology · doi:10.3109/17435390.2011.604442 · Cited by 166
Multi‐Responsive Biodegradable Cationic Nanogels for Highly Efficient Treatment of Tumors
Li, X., Sun, H., Li, H., Hu, C., Luo, Y., Shi, X., & Pich, A. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202100227 · Cited by 166
Self-citationUnderstanding the Chemical Nature of Nanoparticle–Protein Interactions
Baimanov, D., Cai, R., & Chen, C. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00348 · Cited by 165
The biomolecular corona of nanoparticles in circulating biological media
Pozzi, D., Caracciolo, G., Digiacomo, L., Colapicchioni, V., Palchetti, S., Capriotti, A. L., Cavaliere, C., Zenezini Chiozzi, R., Puglisi, A., & Laganà, A. (2015) · Nanoscale · doi:10.1039/c5nr03701h · Cited by 163
Protein Nanoparticle Charge and Hydrophobicity Govern Protein Corona and Macrophage Uptake
Pustulka, S. M., Ling, K., Pish, S. L., & Champion, J. A. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c12341 · Cited by 160
Protein coronas suppress the hemolytic activity of hydrophilic and hydrophobic nanoparticles
Saha, K., Moyano, D. F., & Rotello, V. M. (2013) · Materials Horizons · doi:10.1039/c3mh00075c · Cited by 159
Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers
Corbo, C., Molinaro, R., Taraballi, F., Toledano Furman, N. E., Hartman, K. A., Sherman, M. B., De Rosa, E., Kirui, D. K., Salvatore, F., & Tasciotti, E. (2017) · ACS Nano · doi:10.1021/acsnano.7b00376 · Cited by 155
Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells
Thiele, L., Diederichs, J. E., Reszka, R. C., Merkle, H. P., & Walter, E. (2003) · Biomaterials · doi:10.1016/s0142-9612(02)00525-2 · Cited by 153
Medjeral‐Thomas, N., Lomax-Browne, H. J., Beckwith, H., Willicombe, M. K., Mclean, A. G., Brookes, P., Pusey, C. D., Falchi, M., Cook, H. T., & Pickering, M. C. (2017) · Kidney International · doi:10.1016/j.kint.2017.03.043 · Cited by 153
Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption
Guan, J., Shen, Q., Zhang, Z., Jiang, Z., Yang, Y., Lou, M., Qian, J., Lu, W., & Zhan, C. (2018) · Nature Communications · doi:10.1038/s41467-018-05384-1 · Cited by 152
Plasma Proteome Database as a resource for proteomics research
Muthusamy, B., Hanumanthu, G., Suresh, S., Rekha, B., Srinivas, D., Karthick, L., Vrushabendra, B. M., Sharma, S., Mishra, G., Chatterjee, P., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200401335 · Cited by 152
Givens, B. E., Xu, Z., Fiegel, J., & Grassian, V. H. (2017) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2017.01.011 · Cited by 151
Corona-Directed Nucleic Acid Delivery into Hepatic Stellate Cells for Liver Fibrosis Therapy
Zhang, Z., Wang, C., Zha, Y., Hu, W., Gao, Z., Zang, Y., Chen, J., Zhang, J., & Dong, L. (2015) · ACS Nano · doi:10.1021/nn505166x · Cited by 145
Ren, J., Cai, R., Wang, J., Ghouri, M. D., Baimanov, D., Liu, Y., Yin, D., Liu, Y., Miao, Q., Zhao, Y., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01774 · Cited by 145
Gold Nanoparticle-Enabled Blood Test for Early Stage Cancer Detection and Risk Assessment
Zheng, T., Pierre-Pierre, N., Yan, X., Huo, Q., Almodovar, A. J. O., Valerio, F., Rivera, I., Griffith, E. C., Decker, D., Chen, S., et al. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b00371 · Cited by 142
Non-spherical micro- and nanoparticles for drug delivery: Progress over 15 years
Kapate, N., Clegg, J. R., & Mitragotri, S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.017 · Cited by 142
Chinen, A. B., Guan, C. M., Ko, C. H., & Mirkin, C. A. (2017) · Small · doi:10.1002/smll.201603847 · Cited by 140
Tekie, F. S. M., Hajiramezanali, M., Geramifar, P., Raoufi, M., Dinarvand, R., Soleimani, M., & Atyabi, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-66572-y · Cited by 135
Wang, W., Huang, Z., Li, Y., Wang, W., Shi, J., Fu, F., Huang, Y., Pan, X., & Wu, C. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.10.023 · Cited by 135
The role of complement factor C3 in lipid metabolism
Barbu, A. R., Hamad, O. A., Lind, L., Ekdahl, K. N., & Nilsson, B. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.02.027 · Cited by 133
Insulin‐like growth factor‐ II : its role in metabolic and endocrine disease
Livingstone, C., & Borai, A. (2014) · Clinical Endocrinology · doi:10.1111/cen.12446 · Cited by 132
Hydrophilicity Regulates the Stealth Properties of Polyphosphoester‐Coated Nanocarriers
Simon, J., Wolf, T., Klein, K., Landfester, K., Wurm, F. R., & Mailänder, V. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201800272 · Cited by 129
Blood protein coating of gold nanoparticles as potential tool for organ targeting
Schäffler, M., Sousa, F., Wenk, A., Sitia, L., Hirn, S., Schleh, C., Haberl, N., Violatto, M. B., Canovi, M., Andreozzi, P., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.100 · Cited by 128
Zhang, H., Wu, T., Yu, W., Ruan, S., He, Q., & Gao, H. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b16096 · Cited by 127
Barbalinardo, M., Caicci, F., Cavallini, M., & Gentili, D. (2018) · Small · doi:10.1002/smll.201801219 · Cited by 127
Agrahari, V., Burnouf, P., Burnouf, T., & Agrahari, V. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.02.008 · Cited by 124
Cancer‐Targeted Nanomedicine: Overcoming the Barrier of the Protein Corona
Barui, A. K., Oh, J. Y., Jana, B., Kim, C., & Ryu, J. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900124 · Cited by 123
Biological effects of formation of protein corona onto nanoparticles
Mishra, R. K., Ahmad, A., Vyawahare, A., Alam, P., Khan, T. H., & Khan, R. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.152 · Cited by 121
Wei, Y., Gu, X., Sun, Y., Meng, F., Storm, G., & Zhong, Z. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.012 · Cited by 117
Ustunol, I. B., González-Pech, N. I., & Grassian, V. H. (2019) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2019.06.086 · Cited by 115
When liposomes met antibodies: Drug delivery and beyond
Di, J., Xie, F., & Xu, Y. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.003 · Cited by 115
Markiewicz, M., Kumirska, J., Lynch, I., Matzke, M., Köser, J., Bemowsky, S., Docter, D., Stauber, R. H., Westmeier, D., & Stolte, S. (2018) · Green Chemistry · doi:10.1039/c8gc01171k · Cited by 114
Palchetti, S., Pozzi, D., Capriotti, A. L., Barbera, G. L., Chiozzi, R. Z., Digiacomo, L., Peruzzi, G., Caracciolo, G., & Laganà, A. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.02.037 · Cited by 113
Non-immunotherapy application of LNP-mRNA: Maximizing efficacy and safety
Vlatkovic, I. (2021) · Biomedicines · doi:10.3390/biomedicines9050530 · Cited by 112
The Multiple Facets of Dermcidin in Cell Survival and Host Defense
Schittek, B. (2012) · Journal of Innate Immunity · doi:10.1159/000336844 · Cited by 111
Wang, H., Ding, T., Guan, J., Liu, X., Wang, J., Jin, P., Hou, S., Lu, W., Qian, J., Wang, W., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c02821 · Cited by 103
Varnamkhasti, B. S., Hosseinzadeh, H., Azhdarzadeh, M., Vafaei, S. Y., Esfandyari‐Manesh, M., Mirzaie, Z. H., Amini, M., Ostad, S. N., Atyabi, F., & Dinarvand, R. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.060 · Cited by 102
Feinberg, H., Uitdehaag, J. C. M., Davies, J. M., Wallis, R., Drickamer, K., & Weis, W. I. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg236 · Cited by 102
Weber, C., Morsbach, S., & Landfester, K. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201902323 · Cited by 102
O’Brien, J., & Shea, K. J. (2016) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6b00125 · Cited by 101
Su, G., Jiang, H., Xu, B., Yu, Y., & Chen, X. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00612 · Cited by 99
The need for improved methodology in protein corona analysis
Mahmoudi, M. (2022) · Nature Communications · doi:10.1038/s41467-021-27643-4 · Cited by 94
Piloni, A., Wong, C. K., Chen, F., Lord, M. S., Walther, A., & Stenzel, M. H. (2019) · Nanoscale · doi:10.1039/c9nr06835j · Cited by 92
Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure
Khan, A. U., Khan, M. R., Cho, M. H., & Khan, P. D. M. M. (2020) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-020-02330-8 · Cited by 92
Zhang, T., Zhu, G., Lu, B., Qian, Z., & Peng, Q. (2020) · Medicinal Research Reviews · doi:10.1002/med.21767 · Cited by 89
Alpha-2-Macroglobulin, a Hypochlorite-Regulated Chaperone and Immune System Modulator
Cater, J. H., Wilson, M. R., & Wyatt, A. R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5410657 · Cited by 88
Masaoutis, C., Mihailidou, C., Tsourouflis, G. S., & Theocharis, S. E. (2018) · Biochimie · doi:10.1016/j.biochi.2018.05.014 · Cited by 85
Clemments, A. M., Botella, P., & Landry, C. C. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b01118 · Cited by 81
Disease-related metabolites affect protein–nanoparticle interactions
Tavakol, M., Montazeri, A., Naghdabadi, R., Hajipour, M. J., Zanganeh, S., Caracciolo, G., & Mahmoudi, M. (2018) · Nanoscale · doi:10.1039/c7nr09502c · Cited by 80
Role of protein corona in the biological effect of nanomaterials: Investigating methods
Zeng, L., Gao, J., Liu, Y., Gao, J., Yao, L., Yang, X., Liu, X., He, B., Hu, L., Shi, J., et al. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.05.039 · Cited by 79
Ho, Y. T., Azman, N. ‘., Loh, F. W. Y., Ong, G. K. T., Engudar, G., Kriz, S. A., & Kah, J. C. Y. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00743 · Cited by 78
Cao, X., Han, Y., Li, F., Li, Z., McClements, D. J., He, L., Decker, E. A., Xing, B., & Xiao, H. (2018) · NanoImpact · doi:10.1016/j.impact.2018.12.002 · Cited by 76
Aliyandi, A., Reker‐Smit, C., Bron, R., Zuhorn, I. S., & Salvati, A. L. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00804 · Cited by 75
Protein Corona in Response to Flow: Effect on Protein Concentration and Structure
Jayaram, D. T., Pustulka, S. M., Mannino, R. G., Lam, W. A., & Payne, C. K. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.02.036 · Cited by 73
Enhanced Cancer-targeted Drug Delivery Using Precoated Nanoparticles
Yu, L., Xu, M., Xu, W., Xiao, W., Jiang, X., Wang, L., & Gao, H. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c03982 · Cited by 73
Moghimi, S. M., Simberg, D., Skotland, T., Yaghmur, A., & Hunter, A. C. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258012 · Cited by 69
Tavakoli, S., Kari, O. K., Turunen, T., Lajunen, T., Schmitt, M., Lehtinen, J., Tasaka, F., Parkkila, P., Ndika, J., Viitala, T., et al. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00411 · Cited by 68
Lu, N., Li, J., Tian, R., & Peng, Y. (2014) · Chemical Research in Toxicology · doi:10.1021/tx5001317 · Cited by 66
Effects of gold nanoparticle morphologies on interactions with proteins
Wang, G., Wang, W., Shangguan, E., Gao, S., & Liu, Y. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.110830 · Cited by 66
Durbin, D. M., & Jonas, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31333 · Cited by 64
Modification of the protein corona–nanoparticle complex by physiological factors
Braun, N. J., DeBrosse, M. C., Hussain, S. M., & Comfort, K. K. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.03.059 · Cited by 64
Vidaurre-Agut, C., Rivero-Buceta, E. M., Romaní-Cubells, E., Clemments, A. M., Vera-Donoso, C. D., Landry, C. C., & Botella, P. (2019) · ACS Omega · doi:10.1021/acsomega.9b00460 · Cited by 63
Gao, S., Wake, H., Gao, Y., Wang, D., Mori, S., Liu, K., Teshigawara, K., Takahashi, H. K., & Nishibori, M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14711 · Cited by 62
A Facile Nanoparticle Immunoassay for Cancer Biomarker Discovery
Huo, Q., Colon, J. F., Cordero, A., Bogdanovic, J., Baker, C. H., Goodison, S., & Pensky, M. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-20 · Cited by 61
The biomolecular corona of gold nanoparticles in a controlled microfluidic environment
Digiacomo, L., Palchetti, S., Giulimondi, F., Pozzi, D., Chiozzi, R. Z., Capriotti, A. L., Laganà, A., & Caracciolo, G. (2019) · Lab on a Chip · doi:10.1039/c9lc00341j · Cited by 61
Capillary blood flow imaging within human finger cuticle using optical microangiography
Baran, U., Shi, L., & Wang, R. K. (2013) · Journal of Biophotonics · doi:10.1002/jbio.201300154 · Cited by 59
The influence of shape and charge on protein corona composition in common gold nanostructures
Bewersdorff, T., Glitscher, E. A., Bergueiro, J., Eravci, M., Miceli, E., Haase, A., & Calderón, M. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111270 · Cited by 59
Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment
Meeks, S. L., & Abshire, T. C. (2008) · Haemophilia · doi:10.1111/j.1365-2516.2008.01832.x · Cited by 57
Characterizing the protein corona of sub-10 nm nanoparticles
Glancy, D., Zhang, Y., Wu, J. L. Y., Ouyang, B., Ohta, S., & Chan, W. C. W. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.023 · Cited by 56
Yu, K., Andruschak, P., Yeh, H. H., Grecov, D., & Kizhakkedathu, J. N. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.009 · Cited by 55
Influence of nanoparticle mechanical property on protein corona formation
Tengjisi, Hui, Y., Fan, Y., Zou, D., Talbo, G. H., Yang, G., & Zhao, C. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.08.148 · Cited by 55
Molecular form and concentration of serum α2-macroglobulin in diabetes
Yoshino, S., Fujimoto, K., Takada, T., Kawamura, S., Ogawa, J., Kamata, Y., Kodera, Y., & Shichiri, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-49144-7 · Cited by 53
Natural IgM dominates in vivo performance of liposomes
Ding, T., Guan, J., Wang, M., Long, Q., Liu, X., Qian, J., Wei, X., Lu, W., & Zhan, C. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.018 · Cited by 53
Deciphering Protein Corona by scFv-Based Affinity Chromatography
Chu, Y., Tang, W., Zhang, Z., Li, C., Qian, J., Wei, X., Ying, T., Lu, W., & Zhan, C. (2021) · Nano Letters · doi:10.1021/acs.nanolett.0c04806 · Cited by 50
Unmasking CSF protein corona: Effect on targeting capacity of nanoparticles
Wang, Y., Zhang, H., Xiao, W., Liu, Y., Zhou, Y., He, X., Xia, X., Gong, T., Wang, L., & Gao, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.001 · Cited by 48
Brown, J. M., Bai, W., Raghavendra, A. J., & Podila, R. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s111029 · Cited by 44
Human plasma protein corona decreases the toxicity of pillar-layer metal organic framework
Jafari, S., Izadi, Z., Alaei, L., Jaymand, M., Samadian, H., Kashani, V. O., Derakhshankhah, H., Hayati, P., Noori, F., Mansouri, K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71170-z · Cited by 44
Gros, G., Forster, R. E., & Lin, L. Q. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33310-0 · Cited by 43
Karabasz, A., Szczepanowicz, K., Cierniak, A., Mężyk-Kopeć, R., Dyduch, G., Szczęch, M., Bereta, J., & Bzowska, M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s230865 · Cited by 43
Bychkova, A. V., Lopukhova, M. V., Wasserman, L. A., Degtyarev, Y. N., Kovarski, A. L., Chakraborti, S., & Mitkevich, V. A. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.11.110 · Cited by 42
Caño, R. D., Mateus, L., Sánchez-Obrero, G., Sevilla, J. M., Madueño, R., Blázquez, M., & Pineda, T. (2017) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2017.07.011 · Cited by 41
Formation and biological effects of protein corona for food‐related nanoparticles
Cui, G., Su, W., & Tan, M. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12838 · Cited by 41
A Water-Soluble Photothermal Host–Guest Complex with pH-Sensitive Superlarge Redshift Absorption
Xu, X., Liao, H., Liu, H., Chu, Y., He, Y., & Wang, Y. (2020) · CCS Chemistry · doi:10.31635/ccschem.020.202000505 · Cited by 39
Modulating Protein Corona and Materials–Cell Interactions with Temperature‐Responsive Materials
Prawatborisut, M., Jiang, S., Oberländer, J., Mailänder, V., Crespy, D., & Landfester, K. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202106353 · Cited by 39
Dewald, I., Isakin, O., Schubert, J., Kraus, T., & Chanana, M. (2015) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.5b06266 · Cited by 38
Luby, A. O., Breitner, E. K., & Comfort, K. K. (2015) · Applied Nanoscience · doi:10.1007/s13204-015-0501-z · Cited by 36
Myoglobin induces mitochondrial fusion, thereby inhibiting breast cancer cell proliferation
Braganza, A., Quesnelle, K. M., Bickta, J., Reyes, C., Wang, Y., Jessup, M., Croix, C. M. S., Arlotti, J. A., Singh, S. V., & Shiva, S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006673 · Cited by 36
Huang, B., Yang, Z., Fang, S., Yan, L., Zhong, Z., Zheng, R., Zhang, J., Wang, H., Wang, S., Zou, Q., et al. (2020) · Nanoscale · doi:10.1039/c9nr09405a · Cited by 36
The Protein Corona around Nanoparticles Facilitates Stem Cell Labeling for Clinical MR Imaging
Nejadnik, H., Taghavi-Garmestani, S.-M., Madsen, S. J., Li, K., Zanganeh, S., Yang, P. C.-M., Mahmoudi, M., & Daldrup-Link, H. E. (2017) · Radiology · doi:10.1148/radiol.2017170130 · Cited by 34
Drug-delivering-drug platform-mediated potent protein therapeutics via a non-endo-lysosomal route
Xin, X., Teng, C., Du, X., Lv, Y., Xiao, Q., Wu, Y., He, W., & Yin, L. (2018) · Theranostics · doi:10.7150/thno.23804 · Cited by 34
Self-citationSpreen, H., Behrens, M., Mulac, D., Humpf, H., & Langer, K. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.04.006 · Cited by 33
Li, M., Zhang, X., Li, S., Shao, X., Chen, H., Lv, L., & Huang, X. (2021) · RSC Advances · doi:10.1039/d1ra02116h · Cited by 33
Nemati, M., Bani, F., Sepasi, T., Zamiri, R. E., Rasmi, Y., Kahroba, H., Rahbarghazi, R., Sadeghi, M. R., Wang, Y., Zarebkohan, A., et al. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00525 · Cited by 33
An environmental route of exposure affects the formation of nanoparticle coronas in blood plasma
Grunér, M. S., Kauscher, U., Linder, M. B., & Monopoli, M. P. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.10.028 · Cited by 31
Pourjavadi, A., Tehrani, Z. M., & Mahmoudi, N. (2015) · Journal of Nanoparticle Research · doi:10.1007/s11051-015-3008-3 · Cited by 29
The Protein Corona Does Not Influence Receptor-Mediated Targeting of Virus-like Particles
Suchanova, J. Z., Hejtmánková, A., Neburková, J., Cígler, P., Forstová, J., & Španielová, H. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00240 · Cited by 28
PEGylation and anti-PEG antibodies
Lila, A. S. A., Shimizu, T., & Ishida, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-101750-0.00003-9 · Cited by 27
Huang, Y., Wang, S., Zhang, J., Wang, H., Zou, Q., & Wu, L. (2021) · Nanoscale · doi:10.1039/d1nr03155d · Cited by 26
A Protein Corona Adsorbed to a Bacterial Magnetosome Affects Its Cellular Uptake
Lai, W., Li, D., Wang, Q., Nan, X., Xiang, Z., Ma, Y., Liu, Y., Jiankui, C., Tian, J., & Fang, Q. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s220082 · Cited by 25
Winnersbach, P., Hosseinnejad, A., Breuer, T., Fechter, T., Jakob, F., Schwaneberg, U., Rossaint, R., Bleilevens, C., & Singh, S. (2022) · Membranes · doi:10.3390/membranes12010073 · Cited by 24
Cited by
Multifunctional nanoparticle-mediated combining therapy for human diseases
Li, X., Peng, X., Zoulikha, M., Boafo, G. F., Magar, K. T., Ju, Y., & He, W. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01668-1 · Cited by 521
Self-citationClinical translation of nanomedicines for brain diseases: Current challenges and future directions
Wang, G., Wang, N., Xia, X., Ismail, M., & Shi, B. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114426 · Cited by 33
Li, M., Gao, Z., Lv, H., Sekhar, K. P. C., Song, A., Jiang, X., Hao, J., & Cui, J. (2025) · ACS Nano · doi:10.1021/acsnano.5c03978 · Cited by 31
Metadata
- Authors
- Xiao, Q., Zoulikha, M., Qiu, M., Teng, C., Lin, C., Li, X., Sallam, M. A., Xu, Q., & He, W.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2022-07
- Volume
- 186
- Pages
- 114356
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W4280556428
- Cited by
- 255
- References
- 208
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.